免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:White Depressed Areas and Tumor Infiltrating Lymphocytes: The Cancer Cure That Lies Within?
White Depressed Areas and Tumor Infiltrating Lymphocytes: The Cancer Cure That Lies Within?
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
本简要综述受已故Martin C. Mihm Jr.医生的重要贡献启发;他为认识并深入理解归巢至癌症并浸润其中的淋巴细胞(TIL(肿瘤浸润淋巴细胞),TIL)之间的相互作用奠定了基础。在原发性黑色素瘤中,这一现象可能形成Mihm医生所称的“白色凹陷区域”,成为先见性线索,启发后续尝试调动抗癌免疫。本综述结合肿瘤免疫学领域的近期进展,简要回顾TIL连续发挥作用的关键属性:抗原刺激、归巢,以及效应细胞对靶细胞造成凋亡损伤。本文旨在强调Mihm医生及其同事奠定的基础临床和组织病理学观察如何催生关键预后范式及转化研究见解,并推动癌症免疫治疗领域发生变革。
This brief overview is inspired by seminal contributions by the late Dr. Martin C. Mihm, Jr. who provided a basis for recognition and better understanding of interactions between lymphocytes (tumor-infiltrating lymphocytes [TILs]) that home to and permeate cancers. In primary melanomas, this phenomenon may produce what Dr. Mihm called white depressed areas, prescient clues to what would fuel future attempts at harnessing anticancer immunity.
The critical and sequential TIL attributes of antigenic stimulation, homing, and effector-target cell apoptotic injury herein are briefly reviewed in light of more recent advances in the field of immuno-oncology. The intent is to emphasize how fundamental clinical and histopathological observations, as forged by Dr. Mihm and his associates, have led to critically important prognostic paradigms as well as to translational insights that now have become transformative in the field of cancer immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。